• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Restructuring

Ardian’s Novacap in €310m refinancing

  • Ellie Pullen
  • 12 May 2014
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Ardian-backed French chemicals group Novacap has completed a €310m refinancing on the high-yield bond market.

The issue comprises €310m of senior secured floating rate notes, to mature in 2019. The notes have an interest rate equal to three-month Euribor plus 5% per year.

The company has also secured a €65m super-senior revolving credit facility.

Novacap

  • DEAL:

    Refinancing

  • VALUE:

    €310m

  • LOCATION:

    Lyon

  • SECTOR:

    Speciality chemicals

  • FOUNDED:

    2002

  • STAFF:

    1,245

Goldman Sachs acted as the lead bookrunner for the refinancing, with support from Deutsche Bank, BNP Paribas and Societe Generale.

The refinancing will allow Novacap to continue its ongoing buy-and-build growth strategy under Ardian's ownership.

Previous investment
Ardian (then Axa Private Equity) acquired a 96% stake in Novacap in January 2011. The firm bought the business from Bain Capital via a Rothschild-run auction process. The transaction valued Novacap at €240m.

Ardian invested via its €1.6bn Axa LBO Fund IV. According to unquote" data, a €209m debt package was supplied by BNP Paribas, Societe Generale and HSBC for the buyout.

The GP then supplied acquisition financing to Novacap in November 2011 for the purchase of French chemical group Rhodia's salicylic and acetaminophen businesses, which were renamed Novacyl.

Last year Novacap also acquired a 51% stake in Taixing Yangzi Pharm Chemical, a Chinese producer of para-aminophenol, the main raw material used for the production of paracetamol.

Bain had acquired Novacap in November 2012 for €150m, spinning it out as the European commercial and industrial activities division of Rhodia. A mezzanine facility of €10m was supplied by JP Morgan Private Equity, according to unquote" data.

Company
Lyon-headquartered Novacap produces speciality chemicals for the pharmaceutical, food, animal feed, cosmetics, fragrances and homecare sectors. The group comprises three divisions: mineral specialities, pharmaceuticals and cosmetics, and performance chemicals.

The company employs 1,245 staff and operates 11 facilities worldwide. Novacap claims to have 650 customers across 80 countries.

People
Pierre Luzeau is the president of Novacap. Managing director Thibault Basquin, director Olivier Personnaz, and senior investment manager Arnaud Tardan worked on the transaction for Ardian.

Advisers
Ardian – Latham & Watkins, Thomas Forschbach, Gaetan Gianasso, Natacha Guelibolian (Legal).
Company – White & Case, Colin Chang, Julien Chameyrat, Camille Note (Legal); Latham & Watkins, Olivia Rauch-Ravise, Mathieu Denieau (Legal); PwC Transaction Services, Philippe Gueguen, Philippe Chavanne (Corporate finance).
Management – Opleo Avocats, Pierre-Olivier Bernard, Antoine Degorce (Legal).
Debt – Milbank, Peter Schwartz, Laetitia Costa (Legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Restructuring
  • France
  • Industrials
  • France
  • Refinancing
  • Ardian (formerly Axa PE)
  • Goldman Sachs
  • Deutsche Bank
  • BNP Paribas
  • HSBC

More on Restructuring

Packaging for cosmetics and perfumes
Oxy Capital backs GPack

Deal includes the restructuring of around €60m in debt and the injection of fresh funds, as well as managerial support

  • Turnaround/Special Situations
  • 17 May 2021
Electricity infrastructure
PFR cuts its stake in Enel Russia

Changes are related to the planned change in the ownership structure within Enel Russia's consortium of investors

  • CEE
  • 24 August 2020
Aeroplane engines and aerospace services
Ace Management et al. invest €50m in Mecachrome

Company has benefited from a state-guaranteed loan from its banks with a financing of €60m

  • Restructuring
  • 27 May 2020
Aspirin and other pharmaceutical products
York Capital, Elements Capital buy Pillarstone-backed Famar

In addition to Famar Italia, the Italian subsidiary of Famar, the deal also includes Famar Properties

  • Buyouts
  • 30 March 2020

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013